2001 Best Practices Documentation/Coding 
EB Medicine
AUGUST 1, 2018
Nachi: We’re going to be talking about the pathophysiology of cannabinoids, clinical findings in abuse, best practice management, differences between natural and synthetic cannabinoids, and treatment for cannabinoid hyperemesis syndrome. So buckle up and get ready.
EMDocs
JUNE 2, 2023
mg/kg/dose (IM/IV) Has a FDA Black Box warning in 2001 citing concerns of QT prolongation and torsades de pointes (TdP). Document what you gave and why, as well as the impact. Haloperidol (Haldol) – 0.5-5 5 mg PO; 0.05-0.15 mg/kg IM (up to 5 mg/dose) Chlorpromazine (Thorazine) – 0.55 mg/kg/dose (PO/IM) Droperidol – 0.03-0.07
Expert insights. Personalized for you.
40 
Let's personalize your content